Skip to content
Home/Companies/Biotech/Insilico Medicine
Insilico Medicine

Insilico Medicine

Biotech·France·Active
Entry
–
Hold
–
Status
Active

Who owns Insilico Medicine?

Insilico Medicine is a French Biotech company, currently owned by Warburg Pincus.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Warburg Pincus
Investor
Warburg Pincus
Warburg Pincus Asia Real Estate Fund, L.P. · 2021 · Real Estate

Key facts

HQFrance
SectorBiotech
Websiteinsilico.com

More from Warburg Pincus Asia Real Estate Fund, L.P.

Other portfolio companies in the same fund.

Esr
Active
Business ServicesUS
Genki Forest
Genki Forest
Active
ConsumerUS
Jd Property Group Corporation
Active
China
Jv With Vlinker
Active
China
Kio Jv
Active
China
Lodgis
Lodgis
Active
Singapore

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Insilico Medicine?

Insilico Medicine is currently owned by Warburg Pincus, through Warburg Pincus Asia Real Estate Fund, L.P..

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue